Device Digest

Glenmark Pharmaceuticals’ GRC 54276 Receives FDA Approval for Clinical Trial to Treat Advanced Solid Tumors and Lymphomas

Glenmark Pharmaceuticals’ subsidiary, Glenmark Specialty SA, has received acceptance from the U.S. Food and Drug Administration (FDA) on its Investigational New Drug (IND) application for GRC 54276. The clinical trial will investigate GRC 54276 for the treatment of patients with advanced solid tumors and lymphomas. GRC 54276 is an orally available small molecule hematopoietic progenitor […]

Hospital Updates

Homeopathy treatment protocols are able to reduce thyroid stimulating hormone readings in 52% patients

Homeopathic treatment protocol developed at Dr Kalyan Banerjee’s Clinic are effective in reducing thyroid stimulating hormone readings in 52% hypothyroidism patients within the first follow-up. The results were based on a study of 1200 hypothyroidism patient cases under treatment of doctors at the clinic.  Dr Kalyan Banerjee, Principal Consultant at Dr Kalyan Banerjee’s clinic, informs, […]

Hospital Updates

HCG Cancer Hospital Bengaluru sets a new benchmark for Personalized cancer care with a launch of an AI-based adaptive radiation treatment

To provide patients access to world-class treatment facilities and with a commitment to offering high-quality clinical care, HCG Cancer Hospital, Bengaluru, one of India’s largest dedicated cancer care Hospitals announced the launch of India’s first Varian Ethos™ therapy, an Artificial Intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is […]

Press Announcements

Aster MIMS collaborates with Medtronic to amplify access to stroke care for patients in Kerala

Aster MIMS Hospital, Kozhikode and India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE: MDT), today announced their partnership to build a comprehensive program for stroke patients in Kerala. The program involves a hub and spoke model wherein, Aster MIMS will build a network of identified hospitals in and around Calicut and […]

Digital Health News

Cardiac patients need to be extra cautious during Diwali, Tech-innovation to help prevent after effects

The festival of lights and sweets – Diwali, has once again excited us for merry-making. However, the festive joy with highly saturated sweet delicacies consumed during this period can increase cardiac problems. And these expected conditions affecting the heart on Diwali is known to us. But people are unable to identify a number of external […]

Hospital Updates

Early-stage Kidney Patients Can Manage their Disease with the Right Know-how: Kidney Warriors Foundation

Mumbai-based Kidney Warriors Foundation (KWF) hosted a knowledge workshop with the city’s top Nephrologists to address the concerns and questions of patients living with Chronic Kidney Disease (CKD). The workshop drew upon the expertise of the attending experts to take patients through all the essential steps for slowing down the progressive stages 1-5 of the […]

Drug Updates

Bayer Launches Kerendia™ (finerenone), an Innovative Medicine to Slow Down Progression of Chronic Kidney Disease in Patients with Diabetes

Bayer today announced the launch of Finerenone under the brand name KerendiaTM in India. Finerenone is a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist indicated for patients with chronic kidney disease associated with type 2 diabetes. The recent Indian Chronic Kidney Disease (ICKD) study identifies diabetes as the leading cause of chronic kidney disease and end-stage […]

Device Digest

DCGI approved AstraZeneca’s Lynparza as a monotherapy for adjuvant treatment of patients with high-risk early breast cancer

AstraZeneca India, a leading science-led biopharmaceutical company, today announced that it has received a Drugs Controller General of India (DCGI) approval to market its drug Lynparza (Olaparib) as a monotherapy for the adjuvant treatment of adult patients with BRCA-mutated HER2- negative high-risk early breast cancer, who have previously been treated with neoadjuvant or adjuvant chemotherapy.The […]